Towards energy level cascaded “quantum armours” combating metal corrosion
Yunpeng Liu(Shenyang Institute of Automation), Zijun Ren(Xi'an Jiaotong University), Bo Hou(Electric Power University), Hao Xu(Xi'an Jiaotong University), Frank Marken(University of Bath), Xuanye Yan(Xi'an Jiaotong University), Zhenyu Wang(Shandong University), Wenlong Zhang(Xi'an Jiaotong University), Mingtao Li(Xi'an Jiaotong University), Wei Yan(Xi'an Jiaotong University), Juantao Zhang(Xi'an Jiaotong University), Jinwei Zhu(Xi'an Jiaotong University), Jiangtao Feng(Xi'an Jiaotong University)
Cited by 4
Related Papers
Randomized, Double-Blind, Placebo-Controlled Phase III Trial of Apatinib in Patients With Chemotherapy-Refractory Advanced or Metastatic Adenocarcinoma of the Stomach or Gastroesophageal Junction
|Journal of Clinical Oncology|2016|1k
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
|Clinical Cancer Research|2018|551
Camrelizumab plus carboplatin and pemetrexed versus chemotherapy alone in chemotherapy-naive patients with advanced non-squamous non-small-cell lung cancer (CameL): a randomised, open-label, multicentre, phase 3 trial
|The Lancet Respiratory Medicine|2020|508